[go: up one dir, main page]

HK1039113A1 - Benzothieno Ä3,2-CÜpyridines as alpha2 antagonists - Google Patents

Benzothieno Ä3,2-CÜpyridines as alpha2 antagonists

Info

Publication number
HK1039113A1
HK1039113A1 HK01108819A HK01108819A HK1039113A1 HK 1039113 A1 HK1039113 A1 HK 1039113A1 HK 01108819 A HK01108819 A HK 01108819A HK 01108819 A HK01108819 A HK 01108819A HK 1039113 A1 HK1039113 A1 HK 1039113A1
Authority
HK
Hong Kong
Prior art keywords
cüpyridines
benzothieno
alpha2 antagonists
alpha2
antagonists
Prior art date
Application number
HK01108819A
Other languages
English (en)
Inventor
Ludo Edmond Josephine Kennis
Serge Maria Aloysius Pieters
Francois Paul Bischoff
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1039113A1 publication Critical patent/HK1039113A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK01108819A 1998-10-06 2001-12-15 Benzothieno Ä3,2-CÜpyridines as alpha2 antagonists HK1039113A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203363 1998-10-06
PCT/EP1999/007418 WO2000020422A1 (en) 1998-10-06 1999-10-01 BENZOTHIENO[3,2-c]PYRIDINES AS α2 ANTAGONISTS

Publications (1)

Publication Number Publication Date
HK1039113A1 true HK1039113A1 (en) 2002-04-12

Family

ID=8234188

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01108819A HK1039113A1 (en) 1998-10-06 2001-12-15 Benzothieno Ä3,2-CÜpyridines as alpha2 antagonists

Country Status (28)

Country Link
US (2) US6426350B1 (xx)
EP (1) EP1117667B1 (xx)
JP (1) JP4580555B2 (xx)
KR (1) KR20010071828A (xx)
CN (1) CN1158287C (xx)
AR (1) AR023678A1 (xx)
AT (1) ATE363485T1 (xx)
AU (1) AU760226B2 (xx)
BG (1) BG64625B1 (xx)
BR (1) BR9913110A (xx)
CA (1) CA2346084C (xx)
CZ (1) CZ20011103A3 (xx)
DE (1) DE69936219T2 (xx)
EE (1) EE04835B1 (xx)
ES (1) ES2288025T3 (xx)
HK (1) HK1039113A1 (xx)
HU (1) HUP0103612A3 (xx)
ID (1) ID28280A (xx)
IL (2) IL142442A0 (xx)
NO (1) NO20011309D0 (xx)
NZ (1) NZ509911A (xx)
PL (1) PL347184A1 (xx)
RU (1) RU2222542C2 (xx)
SK (1) SK4312001A3 (xx)
TR (1) TR200100954T2 (xx)
TW (1) TWI251595B (xx)
UA (1) UA70334C2 (xx)
WO (1) WO2000020422A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2305284A3 (en) * 2002-03-08 2012-11-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Use of EGFR transactivation inhibitors in human cancer
JP2005521728A (ja) * 2002-04-03 2005-07-21 オリオン コーポレーション CNS関連疾患のためのα2−アドレナリン受容体アンタゴニストの使用
CN1972938B (zh) 2004-04-12 2010-09-29 大正制药株式会社 环状胺化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3752820A (en) * 1972-03-20 1973-08-14 Colgate Palmolive Co Substituted-1,2,3,4-tetrahydrobenzothieno(3,2-c)pyridine derivatives
FR2570701B1 (fr) * 1984-09-27 1987-05-22 Synthelabo Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines
EP0339959A3 (en) * 1988-04-27 1991-03-20 Glaxo Group Limited Lactam derivatives
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
DE69531476T2 (de) * 1994-09-12 2004-06-09 Lilly Industries Ltd., Basingstoke Serotonergische Modulatoren
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
UA52681C2 (uk) 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі

Also Published As

Publication number Publication date
CA2346084A1 (en) 2000-04-13
CZ20011103A3 (cs) 2001-12-12
JP4580555B2 (ja) 2010-11-17
DE69936219T2 (de) 2008-02-07
DE69936219D1 (de) 2007-07-12
ES2288025T3 (es) 2007-12-16
EP1117667B1 (en) 2007-05-30
ATE363485T1 (de) 2007-06-15
US20020169178A1 (en) 2002-11-14
US6774129B2 (en) 2004-08-10
IL142442A (en) 2006-10-05
KR20010071828A (ko) 2001-07-31
HUP0103612A3 (en) 2003-03-28
BR9913110A (pt) 2001-05-08
ID28280A (id) 2001-05-10
BG64625B1 (bg) 2005-09-30
IL142442A0 (en) 2002-03-10
EE04835B1 (et) 2007-06-15
NZ509911A (en) 2002-09-27
HUP0103612A2 (hu) 2002-01-28
AU760226B2 (en) 2003-05-08
CN1158287C (zh) 2004-07-21
PL347184A1 (en) 2002-03-25
AU6089999A (en) 2000-04-26
BG105331A (en) 2001-11-30
RU2222542C2 (ru) 2004-01-27
EP1117667A1 (en) 2001-07-25
TR200100954T2 (tr) 2001-12-21
NO20011309L (no) 2001-03-15
US6426350B1 (en) 2002-07-30
CN1321159A (zh) 2001-11-07
AR023678A1 (es) 2002-09-04
SK4312001A3 (en) 2001-12-03
JP2002526546A (ja) 2002-08-20
TWI251595B (en) 2006-03-21
WO2000020422A1 (en) 2000-04-13
CA2346084C (en) 2010-01-26
NO20011309D0 (no) 2001-03-15
UA70334C2 (en) 2004-10-15
EE200100206A (et) 2002-06-17

Similar Documents

Publication Publication Date Title
IL140197A0 (en) β-CARBOLINE COMPOUNDS
EG24743A (en) Heterocyclic compounds.
ZA200203581B (en) Bicyclic imidazo-3-yl-amine derivatives.
HUP0203375A3 (en) Substituted oxoazaheterocyclyl compounds
HRP20020102B1 (en) Novel spiro compounds
ZA200108968B (en) New compounds.
HUP0101753A3 (en) Boring-tool
GB9826359D0 (en) Novel receptors
EG24605A (en) Antihistaminic spiro compounds
ZA200110021B (en) Substituted imidazothiazoles as antidepressant agents.
IL137329A0 (en) Vla-4 antagonists
EG22286A (en) Fungicidal combinations comprising thieno ä2,3-dü pyrimidin-4-one
EP1210978A4 (en) PIPETTES DEVICE
EP0986553A4 (en) DIHYDROPYRIMIDONE DERIVATIVES AS NPY ANTAGONISTS
PL353372A1 (en) Substituted heterocyclyl-2h-chromenes
HK1039113A1 (en) Benzothieno Ä3,2-CÜpyridines as alpha2 antagonists
GB9911456D0 (en) Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives
PL352101A1 (en) Substituted phenylcyclohexanocarboxyamides
ZA99171B (en) Piperazino derivatives as neurokinin antagonists.
ZA200108302B (en) Substituted bicyclic heteroaryl compounds as integrin antagonists.
GB9918623D0 (en) Lathe
PL343921A1 (en) Toolhead
ZA200203582B (en) Bicyclic imidazo-5-yl-amine derivatives.
TW401868U (en) Improved drill
ZA200200734B (en) Spiro compounds.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101001